Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:57 AM
Ignite Modification Date:
2025-12-25 @ 2:57 AM
NCT ID:
NCT00475033
Eligibility Criteria:
Inclusion Criteria:
* Healthy 2-month old infants (42 to 98 days)
* Available for the duration of the study and reachable by telephone
Exclusion Criteria:
* Previous vaccination with licensed or investigational pneumococcal, Hib conjugate, diphtheria, tetanus, pertussis, polio, or meningococcal vaccine
* Previous anaphylactic reaction to any vaccine or vaccine-related component.
* Bleeding disorder, immune deficiency or suppression, or significant chronic or congenital disease
* Receipt of blood products or gamma globulin
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
42 Days
Maximum Age:
98 Days
Study:
NCT00475033
Study Brief:
Protocol Section:
NCT00475033